Skip to main content
Caplight Logo









Oncko

Oncko

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.oncko.com/

Last Round

Seed

Feb 1, 2026

Total Funding Raised

$5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Oncko is a biotechnology company that develops optimized combination drug therapies to treat advanced cancers by leveraging experimental platforms and machine learning.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverycombination therapyoncologyprecision medicineAI drug discoveryin silico drug designbiotechcancer researchhigh-throughput screeningcomputational biologydrug optimizationNSCLCCRCnon-small cell lung cancercolorectal cancerpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncko Comparables

Compare Oncko with similar companies based on industry and business-model similarity.

Oncko comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Noetik
74%
PerturbAI
72%
Certis Oncology Solutions
71%

Oncko Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 1, 2026

Key People

Founding team and executive leadership

Atray Dixit

Co-Founder and CEO

Founding Team

Reka Tron

Fractional COO

Executive Team

Oncko Investors

Notable investors and investment history

Oncko investors
InvestorRounds
GaingelsSeed
Adverb VenturesSeed
TenmileSeed
Illumina VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 9, 2026

    Grew 50% QoQ, from 6 to 9 employees.

  • Feb 1, 2026

    $5M round with participation from Gaingels and Illumina Ventures.

Oncko Filings

Explore SEC and related filing metadata, where available.

Oncko filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oncko's valuation, stock price, and market status.

Is Oncko a public or private company?

Oncko is a private company.

What is the current stock price of Oncko?

Oncko is a private company with no public stock price. Caplight tracks Oncko's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Oncko worth (valuation)?

Valuation information for Oncko is not publicly available.

Can I buy Oncko stock?

Oncko shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oncko's last funding round?

Oncko's most recent funding round was Seed on February 1, 2026.

Who are the main investors in Oncko?

Key investors in Oncko include Gaingels, Adverb Ventures, Tenmile, Illumina Ventures.

Will Oncko IPO soon?

No public IPO plans have been announced for Oncko.

How can I track Oncko secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oncko's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2024
Last FundingFeb 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?